Sabrina Stöckl
Principal,
b2venture
Sabrina Stöckl is Principal at b2venture, focusing on life sciences, biotech, and healthtech.
She studied business at the WHU - Otto Beisheim School of Management and received a double Master’s in Management and Innovation from the HEC Paris and Technical University of Munich.
Sabrina began her career in investment banking focusing on equities and capital markets, before moving into VC. She primarily invests in areas where medical breakthroughs and innovation can have the biggest impact. She is particularly interested in oncology and has developed a life-long passion for solutions that address longevity. Her recent investments include eGenesis and Medical Microinstruments.
Sessions
-
03-Oct-2024Spotlight StageA health-AI-er future: Diagnosing what's next